Development of a sirolimus-eluting poly (l-lactide)/poly(4-hydroxybutyrate) absorbable stent for peripheral vascular intervention

References

[1] Biamino G, Schmidt A, Scheinert D. Treatment of SFA lesions with PLLA biodegradable stents: results of the PERSEUS study. J Endovasc Ther 2005; 12(Suppl. I): I–5.Search in Google Scholar

[2] Bosiers M, Peeters P, D’Archambeau O, et al. AMS INSIGHT – absorbable metal stent implantation for treatment of below-the-knee critical limb ischemia: 6-month analysis. Cardiovasc Intervent Radiol 2009; 32: 424–435.10.1007/s00270-008-9472-8Search in Google Scholar

[3] Brown DA, Lee EW, Loh CT, Kee ST. A new wave in treatment of vascular occlusive disease: biodegradable stents – clinical experience and scientific principles. J Vasc Interv Radiol 2009; 20: 315–324.10.1016/j.jvir.2008.11.007Search in Google Scholar

[4] Bünger CM, Grabow N, Kröger C, et al. Iliac anastomotic stenting with a sirolimus-eluting biodegradable poly-L-lactide stent: a preliminary study after 6 weeks. J Endovasc Ther 2006; 13: 630–639.10.1583/06-1899R.1Search in Google Scholar

[5] Bünger CM, Grabow N, Sternberg K, et al. Sirolimus-eluting biodegradable poly-l-lactide stent for peripheral vascular application: a preliminary study in porcine carotid arteries. J Surg Res 2007; 139: 77–82.10.1016/j.jss.2006.07.035Search in Google Scholar

[6] Chichkov B, Momma C, Nolte S, von Alvensleben F, Tunnermann A. Femtosecond, picosecond and nanosecond laser ablation of solids. Appl Phys A 1996; 63: 109–115.10.1007/BF01567637Search in Google Scholar

[7] Colombo A, Hall P, Nakamura S, et al. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation 1995; 91: 1676–1688.10.1161/01.CIR.91.6.1676Search in Google Scholar

[8] Dudek D, Onuma Y, Ormiston JA, Thuesen L, Miquel-Hebert K, Serruys PW. Four-year clinical follow-up of the ABSORB everolimus-eluting bioresorbable vascular scaffold in patients with de novo coronary artery disease: the ABSORB trial. EuroIntervention 2012; 7: 1060–1061.10.4244/EIJV7I9A168Search in Google Scholar

[9] Erbel R, Di Mario C, Bartunek J, et al. Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial. Lancet 2007; 369: 1869–1875.10.1016/S0140-6736(07)60853-8Search in Google Scholar

[10] Grabow N, Bunger C, Sternberg K, Mews S, Schmohl K, Schmitz KP. Mechanical properties of a biodegradable balloon-expandable stent from poly(L-lactide) for peripheral vascular applications. ASME J Med Devices 2007; 1: 84–88.10.1115/1.2355683Search in Google Scholar

[11] Grabow N, Bünger CM, Schultze C, et al. A biodegradable slotted tube stent based on poly(L-lactide) and poly(4-hydroxybutyrate) for rapid balloon-expansion. Ann Biomed Eng 2007; 35: 2031–2038.10.1007/s10439-007-9376-9Search in Google Scholar PubMed

[12] Grabow N, Schmitt L, Pfensig S, et al. Spray-coating process development, manufacture, quality assessment and drug release behavior of peripheral drug-eluting stents. Biomed Tech (Berl) 2012 Sep 6. DOI:10.1515/bmt-2012-4298.10.1515/bmt-2012-4298Search in Google Scholar

[13] Holmes DR Jr., Moses JW, Schofer J, Morice MC, Schampaert E, Leon MB. Cause of death with bare metal and sirolimus-eluting stents. Eur Heart J 2006; 27: 2815–2822.10.1093/eurheartj/ehl385Search in Google Scholar PubMed

[14] Joner M, Finn AV, Farb A, et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 2006; 48: 193–202.10.1016/j.jacc.2006.03.042Search in Google Scholar PubMed

[15] Onuma Y, Serruys PW. Bioresorbable scaffold: the advent of a new era in percutaneous coronary and peripheral revascularization? Circulation 2011; 123: 779–797.10.1161/CIRCULATIONAHA.110.971606Search in Google Scholar PubMed

[16] Ormiston JA, Webster MW, Armstrong G. First-in-human implantation of a fully bioabsorbable drug-eluting stent: the BVS poly-L-lactic acid everolimus-eluting coronary stent. Catheter Cardiovasc Interv 2006; 69: 128–131.10.1002/ccd.20895Search in Google Scholar PubMed

[17] Schmidt W, Schmitz KP. Devices. In: Lanzer P, editor. Mastering of endovascular techniques – A guide to excellence. Philadelphia: Lippincott Williams & Wilkins 2006: 114–135.Search in Google Scholar

[18] Schmidt W, Andresen R, Behrens P, Schmitz KP. Characteristic mechanical properties of balloon-expandable peripheral stent systems. Rofo-Fortschr Rontg 2002; 174: 1430–1437.10.1055/s-2002-35345Search in Google Scholar PubMed

[19] Schmidt W, Schmitz KP, Behrens P, Behrend D, Lootz D. Is a standardized measurement of the elastic recoil of coronary stents under vascular conditions necessary and meaningful? Prog Biomed Res 2000; 5: 204–210.Search in Google Scholar

[20] Standard Guide for Measuring Securement of Balloon Expandable Vascular Stent Mounted on Delivery System. ASTM F2394–07 (2013).Search in Google Scholar

[21] Tamai H, Igaki K, Kyo E, et al. Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans. Circulation 2000; 102: 399–404.10.1161/01.CIR.102.4.399Search in Google Scholar

[22] Tan LP, Venkatraman SS, Joso JF, Boey FY. Collapse pressures of bilayered biodegradable stents. J Biomed Mater Res B Appl Biomater 2006; 79: 102–107.10.1002/jbm.b.30518Search in Google Scholar PubMed